Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ORION CORPORATION STOCK EXCHANGE RELEASE 22 JUNE 2010 AT 8.30 a.m. EET Orion Corporation ("Orion") and Sun Pharmaceutical Industries Limited and certain other companies belonging to Sun...
-
ORION CORPORATION STOCK EXCHANGE RELEASE 17 JUNE 2010 AT 8.50 AM EET In accordance with Section 3 of the Articles of Association of Orion Corporation, 20,138 A-shares have been converted into...
-
ORION CORPORATION STOCK EXCHANGE RELEASE 15 June 2010 AT 01.55 EET The Board of Directors of Orion Corporation has decided to complement the composition of the R&D Committee with Matti...
-
ORION CORPORATION STOCK EXCHANGE RELEASE 14 June 2010 at 10:15 EET The positive earnings development reported by the Orion Group for the first quarter of 2010 has continued showing...
-
ORION CORPORATION STOCK EXCHANGE RELEASE 1 JUNE 2010 AT 9.00 AM EET In accordance with Section 3 of the Articles of Association of Orion Corporation, 1,100,000 A-shares have been converted into...
-
ORION CORPORATION STOCK EXCHANGE RELEASE 18 May 2010 AT 12:45 EET The Board of Directors of Orion Corporation decided on 18 May 2010 on a share repurchase based on the authorisation by the...
-
ORION CORPORATION STOCK EXCHANGE RELEASE 18 May 2010 AT 12:30 EET Mr. Pekka Kaivola, Senior Vice President responsible for the Global Sales line function of the Orion Group and member of the...
-
ORION CORPORATION STOCK EXCHANGE RELEASE 30 APRIL 2010 AT 9.00 AM EET In accordance with Section 3 of the Articles of Association of Orion Corporation, 1,700,000 A-shares have been converted...
-
ORION CORPORATION INTERIM REPORT JANUARY-MARCH 2010 27 April 2010 at 12:00 EEST Orion's net sales for January-March 2010 totalled EUR 214.5 million (EUR 190.1 million for January-March...
-
ORION CORPORATION STOCK EXCHANGE RELEASE 20 APRIL 2010 AT 8.30 AM EET The initial results of the MIDEX and PRODEX studies conducted by Orion Corporation with dexmedetomidine indicate that...